martes, 3 de marzo de 2020

The coronavirus could help pharma reset its reputation in Washington

The coronavirus could help pharma reset its reputation in Washington

Morning Rounds

Shraddha Chakradhar

What to read around the web today

  • FDA petitioned to recall batches of metformin diabetes pill over a possible carcinogen. STAT Plus
  • Psychedelic therapy is on the cusp of legalization—and plagued with sexual abuse allegations. Quartz
  • Azar in the crosshairs for delays in virus tests. Politico
  • Supreme Court will decide the fate of Obama health care law. Associated Press
  • The coronavirus could help pharma reset its reputation in Washington. STAT

No hay comentarios: